RELATED STUDY

Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

Key Findings:  This review discusses the promising available research on the activity of cannabinoids on the skin's endocannabinoid system, which could result in effective treatments for atopic dermatitis, psoriasis, and allergic contact dermatitis conditions. Further human studies are needed, on topical preparations, as oral compounds appear to have more side effects than topical at this juncture.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Portugal

Year of Pub:  2022


Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Tetrahydrocannabinolic Acid (THC-a), JWH-x Synthetic Cannabinoids, HU-x Synthetic Cannabinoids, SR-x Synthetic Cannabinoids, Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL), Virodhamine (O-AEA), Cannabinoid (unspecified), Synthetic Cannabinoid (unspecified), Endocannabinoid (unspecified), Pharma THC, Pharma THC:CBD, Pharma CBD, Tetrahydrocannabivarin (THCV), Delta-8-THC, Palmitoylethanolamide (PEA)

Phytocannabinoid Source:  Unspecified

Terpenes Studied:  Limonene, Myrcene, Pinene

Receptors Studied:  CB1, CB2, TRPs, PPARs

Ligands Studied:  Serotonin

Route of Administration:  Topical



Link to study